Company Filing History:
1 out of 7 
1 out of 4 
1 out of 1 Years Active: 2020-2025
Title: Zhenquan Hu: Innovator in Kinase Inhibition
Introduction
Zhenquan Hu is a prominent inventor based in Anhui, China. He has made significant contributions to the field of kinase inhibitors, particularly in the development of selective compounds that target specific kinases involved in various diseases.
Latest Patents
Zhenquan Hu holds 2 patents that showcase his innovative work. His latest patents include a "Selective PI3Kδ inhibitor and use thereof," which relates to a compound serving as a selective PI3Kδ kinase inhibitor. This compound can be used to inhibit PI3Kδ kinase activity or to treat diseases associated with its activity. Another notable patent is the "Selective C-KIT kinase inhibitor," which provides a compound that can be used for preventing or treating diseases caused by the activity of the tyrosine kinase C-KIT, particularly cancers and other cell proliferation diseases.
Career Highlights
Throughout his career, Zhenquan Hu has worked with various companies, including Tarapeutics Science Inc. and Precedo Pharmaceuticals Co., Ltd. His work has focused on developing innovative therapeutic agents that address critical health challenges.
Collaborations
Zhenquan Hu has collaborated with notable colleagues, including Qingsong Liu and Jing Liu. These collaborations have contributed to the advancement of his research and the development of effective therapeutic solutions.
Conclusion
Zhenquan Hu's contributions to the field of kinase inhibitors highlight his role as an influential inventor. His innovative patents and collaborations reflect his commitment to advancing medical science and improving treatment options for various diseases.